Loading...
Sorafenib and sunitinib: A dermatologist's perspective
Sorafenib and sunitinib are inhibitors of tumor angiogenesis have recently generated curiosity regarding its role in cutaneous toxicities, which has severely affected the daily activities resulting in interruption or dose modification of therapy in renal cell carcinoma and hepatocellular carcinomas....
Na minha lista:
| Main Authors: | , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Medknow Publications & Media Pvt Ltd
2014
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3937473/ https://ncbi.nlm.nih.gov/pubmed/24616845 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/2229-5178.126017 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|